Mergers and acquisitions

BMS to Shutter Ex-Amylin Facility - Redundancies Inevitable

09-Apr-2013 - Bristol-Myers Squibb says shuttering Amylin’s San Diego facilities will accelerate its diabetes R&D joint venture with AstraZeneca though approximately 300 jobs will be lost.

AmerisourceBergen Exits Contract Packaging and Canadian Distribution

03-Apr-2013 - AmerisourceBergen has sold AndersonBrecon for $308m, exiting the contract packaging business in order to concentrate on its core business.

Shire's Vision Strengthened with $160m Acquisition

26-Mar-2013 - Shire says it is laying down a foundation into the specialty ophthalmology field following its second acquisition in a matter of weeks.

AB Technology Buys Angel's Edinburgh Assets

19-Mar-2013 - As the dissolution of Angel continues, its core manufacturing facility has been bought by AB Technology ensuring long term operations and rescuing 23 jobs.

Fallen Angel Sells Collagen Supply Wing to Collbio

18-Mar-2013 - Following last week’s shuttering of a manufacturing plant administrators have sold Angel Biomedical to new company Collbio as they start offloading CMOs assets.

Actavis Shutters Unit Following Watson Takeover R&D Double-Up

14-Mar-2013 - Following an analysis of its global R&D business Actavis says it will close its Maltese R&D unit at a cost of 60 jobs.

Patheon to Shutter Manufacturing Plant as Part of Banner Integration

12-Mar-2013 - Patheon says the shuttering of one of Banner’s manufacturing sites is necessary in integrating the recent acquisition into its global business structure.

Mylan Buys Agila Citing Global Injectable Drug Shortages as Driver

04-Mar-2013 - Mylan says its acquisition of Agila puts the generics company in a “leading position” in the injectables market.

Capsugel Buys Encap as Part of Dosage Form Solution Strategy

01-Mar-2013 - Capsugel says the acquisition of Encap is part of its recently announced Dosage Form Solutions (DFS) strategy.

Oral Dose Competition Intensifies as Qualicaps Expands Manufacturing

26-Feb-2013 - Following a bout of investments, the oral dose solution market has been described as “competitive” and “dynamic” by two of the major players.

IMCD Buys Indian Distributor Indchem for Pharma business

20-Feb-2013 - Chemical distributor IMCD Group says acquisition of Mumbai-based Indchem will build its presence in the Indian pharmaceutical sxcipient sector.

Unichem Sell Indian Formulation Plant to Mylan

19-Feb-2013 - Mylan Laboratories has purchased a new finished formulations facility in an Indian Special Economic Zone from Unichem Laboratories.

Merck: ‘In-House API Production Remains Important Strategy’

14-Feb-2013 - Merck says it will keep in-house API production capacity as it continues to evaluate its manufacturing strategy.

Update

Teva to Sell Californian Plant as Part of Cost-Cutting Initiative

11-Feb-2013 - Teva says the offloading of its Californian manufacturing facility is part of cost-cutting plans designed to save $2bn (€1.5bn). in the next few years.

News in brief

Sun Takeover Bid Burns Out as Taro Grows

11-Feb-2013 - Sun Pharmaceutical Industries has abandoned its long running efforts to buy Israel’s Taro, explaining the move is in the best interest of shareholders.

breaking news - update

BASF sees synergies between new acquisition Pronova and Equateq

21-Jan-2013 - BASF has had its offer for omega-3 API maker Pronova Biopharma accepted by 97.7 per cent of the Norwiegan firm’s shareholders.

Exclusive - update

Odin likely to accept revised offer for Pronova says BASF

18-Jan-2013 - German chemicals giant BASF expects its revised takeover bid for Norwegian omega-3 API manufacturer Pronova Biopharma ASA to be accepted by resistant shareholders.

update

Greece is the word: BASF tells Pronova shareholders revised bid is fair value

15-Jan-2013 - BASF says revised offer for omega-3 API maker Pronova Biopharma is fair value given recent Greek Government decision to stop reimbursing two key drugs. 

Symrise-Probi partnership to deliver probiotic goods in 2014-15

20-Dec-2012 - German fragrance and flavours house Symrise has just last night inked a deal with Swedish probiotics firm Probi to develop a stand-alone R&D project with oral probiotic supplements the most...

BASF commits €22m as it expands Scottish omega-3 venture 1000%

10-Dec-2012 -

Equateq, Cognis and Pronova: “Each are complementary”, says BASF

26-Nov-2012 - BASF’s ever-expanding nutrition unit says its €644m bid last week bid for Norwegian omega-3 firm, Pronova Biopharma, is as important for its food supplements business as its pharmaceutical operations.

CPhI Worldwide 2012: Networking, up-coming countries and bioavailability

08-Oct-2012 - in-Pharmatechnologist.com is going to Madrid, Spain to meet API and excipient makers, Biopharma firms, processing tech developers and contract services organisation gathered for one of the drug industry's biggest trade shows....

BD hunting "plug in" acquisitions

07-Aug-2012 - BD is on the lookout for more acquisitions with firms it can easily “plug in” to its business.

EXCLUSIVE

Invest in African R&D to boost manufacturing: WAPMA and PMGMAN's plea

23-Jul-2012 - WAPMA and PMGMAN are calling on African Governments to pump more money into R&D in order to boost the continent’s pharmaceutical manufacturing sector.